Usefulness of epithelial cell adhesion molecule expression in the algorithmic approach to Lynch syndrome identification

Human Pathology

Volumn 44, Issue 3, 2013, Pages 412-416

  Musulen, Eva ^a   Blanco, Ignacio ^b   Carrato, Cristina ^a   Fernandez Figueras, Maria Teresa ^a   Pineda, Marta ^b   Capella, Gabriel ^b   Ariza, Aurelio ^a  

^a HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

^b CATALAN INSTITUTE OF ONCOLOGY   (Spain)

Author keywords

Colorectal carcinoma; EPCAM expression; EPCAM gene; Lynch syndrome; MSH2 gene

Indexed keywords

EPITHELIAL CELL ADHESION MOLECULE; PROTEIN MSH2;

ADULT; AGED; ALGORITHM; ARTICLE; CLINICAL ARTICLE; COLORECTAL CARCINOMA; CONTROLLED STUDY; EXON; FEMALE; GENE DELETION; GERM LINE; HEREDITARY NONPOLYPOSIS COLORECTAL CANCER; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTRON; MALE; PROTEIN EXPRESSION;

ADULT; AGED; AGED, 80 AND OVER; ALGORITHMS; ANTIGENS, NEOPLASM; CELL ADHESION MOLECULES; COLORECTAL NEOPLASMS, HEREDITARY NONPOLYPOSIS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GERM-LINE MUTATION; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; MUTS HOMOLOG 2 PROTEIN; PROSPECTIVE STUDIES; SEQUENCE DELETION;

EID: 84873710303     PISSN: 00468177     EISSN: 15328392     Source Type: Journal    
DOI: 10.1016/j.humpath.2012.06.006     Document Type: Article

References (13)

1. H.T. Lynch, P.M. Lynch, S.J. Lanspa, C.L. Snyder, J.F. Lynch, and C.R. Boland Review of the Lynch syndrome: history, molecular genetics, screening, differential diagnosis, and medicolegal ramifications Clin Genet 76 2009 1 18
2. K.W. Jasperson, T.M. Tuohy, D.W. Neklason, and R.W. Burt Hereditary and familial colon cancer Gastroenterology 138 2010 2044 2058
3. M.J. Ligtenberg, R.P. Kuiper, and T.L. Chan Heritable somatic methylation and inactivation of MSH2 in families with Lynch syndrome due to deletion of the 3′ exons of TACSTD1 Nat Genet 41 2009 112 117
4. C. Guarinos, A. Castillejo, and V.M. Barberá EPCAM germ line deletions as causes of Lynch syndrome in Spanish patients J Mol Diagn 12 2010 765 770
5. T. Nagasaka, J. Rhees, and M. Kloor Somatic hypermethylation of MSH2 is a frequent event in Lynch syndrome colorectal cancers Cancer Res 70 2010 3098 3108
6. K. Rumilla, K.V. Schowalter, and N.M. Lindor Frequency of deletions of EPCAM (TACSTD1) in MSH2-associated Lynch syndrome cases J Mol Diagn 13 2011 93 99
7. S.V. Litvinov, M.P. Velders, H.A. Bakker, G.J. Fleuren, and S.O. Warnaar Ep-CAM: a human epithelial antigen is a homophilic cell-cell adhesion molecule J Cell Biol 125 1994 437 446
8. M.J. Winter, I.D. Nagtegaal, J.H. van Krieken, and S.V. Litvinov The epithelial cell adhesion molecule (Ep-CAM) as a morphoregulatory molecule is a tool in surgical pathology Am J Pathol 163 2003 2139 2148
9. M. Kloor, A.Y. Voigt, and H.K. Schackert Analysis of EPCAM protein expression in diagnostics of Lynch syndrome J Clin Oncol 29 2011 223 227
10. M.J. Kempers, R.P. Kuiper, and C.W. Ockeloen Risk of colorectal and endometrial cancers in EPCAM deletion-positive Lynch syndrome: a cohort study Lancet Oncol 12 2011 49 55
11. R.P. Kuiper, L.E. Vissers, and R. Venkatachalam Recurrence and variability of germline EPCAM deletions in Lynch syndrome Hum Mutat 32 2011 407 414
12. M.E. Kovacs, J. Papp, Z. Szentirmay, S. Otto, and E. Olah Deletions removing the last exon of TACSTD1 constitute a distinct class of mutations predisposing to Lynch syndrome Hum Mutat 30 2009 197 203
13. L. Pérez-Cabornero, M. Infante Sanz, and E. Velasco Sampedro Frequency of rearrangements in Lynch syndrome cases associated with MSH2: characterization of a new deletion involving both EPCAM and the 5′ part of MSH2 Cancer Prev Res (Phila) 4 2011 1556 1562